Friday, 4 May 2018

FDA approves Novartis combo therapy for aggressive type of thyroid cancer

(Reuters) - The U.S. Food and Drug Administration on Friday approved Novartis AG's combination therapy to treat an aggressive type of thyroid cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)